Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NatRevRheumatol
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NatRevRheumatol
-
Prikvačeni tweet
Our Key Advances in Rheumatology
#collection contains all of our#YearinReview articles for 2019, along with a selection of articles on related subjects so you can dive further into the topics discussed. https://go.nature.com/36yhR8h#rheumtwitter#rheumatwitter#rheumatologypic.twitter.com/sWT4ty7kMA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | Positive results for anifrolumab in phase III SLE trial#lupus#TULIP2#anifrolumab#therapy#rheumtwitter Read the original research from@NEJM here https://bit.ly/31pT70a Read our#news story herehttps://go.nature.com/2S0vxnRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | EULAR updates its RA management recommendations#EULAR#arthritis#therapy Read the original research from@ARD_BMJ here https://bit.ly/2tuUgHu Read our#news story here https://go.nature.com/31kJXlG pic.twitter.com/zXMTPrpvCp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | Risk variant in long noncoding RNA linked to SLE |#Lupus#Genetics Read the original research from@ACR_Journals here https://bit.ly/36G1cyU Read our news story herehttps://go.nature.com/36R9kNiHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | Long-term safety of ixekizumab confirmed in#PsoriaticArthritis Read the original research from@ArthritisRes here https://bit.ly/31eKh5t Read our news story herehttps://go.nature.com/2S5wTwmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | Knee#Osteoarthritis increases risk of all-cause mortality Read the original research from@ACR_Journals here https://bit.ly/31arp7I Read our news story herehttps://go.nature.com/31arjgmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | CD40 blockade shows promise in pSS trial |#SjogrenSyndrome#Therapy Read the original research from@TheLancetRheum here https://bit.ly/2uPRI76 Read our news story herehttps://go.nature.com/36LhRkPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | New#Osteoarthritis management guidelines Read the original research from@ACR_Journals here https://bit.ly/38PIyGi Read our news story herehttps://go.nature.com/2tgYhPGHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchHighlight | European consensus reached on interstitial#lung disease in#SystemicSclerosis Read the original research from@TheLancetRheum here https://bit.ly/2tV6QQy Read our news story herehttps://go.nature.com/37G7YWRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our new
#NewsAndViews article from Anne Musters and Sander Tas is now online: Room for improvement in clinical trials for rare diseases Check it out at https://go.nature.com/2OakIx0 pic.twitter.com/0tMBGaT03x
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#YearInReview on#NETs in rheumatic diseases Studies in 2019 have shown how genetic susceptibilities to#autoimmunity can promote NET-mediated#inflammation, and expanded the role for NETs Read the full article at https://go.nature.com/2Gw1g9Q pic.twitter.com/GzLgPwBMgx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#Review on Immunological adaptations in#Pregnancy that modulate#RheumatoidArthritis disease activity Read for#free at https://rdcu.be/b0lKo#SharedItpic.twitter.com/nEMC8tZ1qZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#YearInReview on#Opioids in#Rheumatology Studies in 2019 reported the trends and safety of opioids in patients with#RheumatoidArthritis or#Osteoarthritis@SeoyoungCKim Read the full article at https://go.nature.com/3aOA5Fd pic.twitter.com/mUCp9oXIjf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue | T cell metabolism: new insights in systemic#lupus erythematosus#pathogenesis and#therapy Check out the#Review at https://go.nature.com/2Rx2tCX#Immunometabolism#Tcellspic.twitter.com/KISPTyaNuO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#YearInReview on#MachineLearning in#Rheumatology Several studies in 2019 highlight the feasibility and clinical utility of using#MachineLearning in#rheumatology Check it out at https://go.nature.com/3aLY87E@PanditAridaman@UMCUtrecht@UMCURRCIpic.twitter.com/geoDO7BVKb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#Review on immune monitoring using mass cytometry and related high-dimensional#imaging approaches Check it out at https://go.nature.com/37sjZhT#Rheumatology#Immunology@felixjhartmann@Bendall_Labpic.twitter.com/OuMB1owI7x
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#YearInReview on#synovial tissue analysis In 2019, new technologies for examining the molecular characteristics of specific cell#subsets have enabled advances in our understanding of the architecture of synovial tissue Read more at https://go.nature.com/2GvYjGs pic.twitter.com/peiLVscHsM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue | Asymptomatic#hyperuricaemia: a silent activator of the innate immune system Read the#Review at https://go.nature.com/2t7r9JI pic.twitter.com/Ed5pnZUn55
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue |#YearInReview on#biosimilars Studies in 2019 support the effectiveness and safety of nonmedical switching and the benefits of communicating information about biosimilars to patients in a positive light.@RheumKay Check it out at https://go.nature.com/3aSwwO7 pic.twitter.com/wN75TMoQLe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FebruaryIssue | Key advances in#Rheumatology from 2019. Check out our Key Advances in Rheumatology#collection at https://go.nature.com/36yhR8h#rheumtwitter#rheumatwitter#rheumatologypic.twitter.com/SvoyOGUezK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#FebruaryIssue is out now with articles on asymptomatic#hyperuricaemia, T cell#immunometabolism in#lupus, immunomodulatory mechanisms during#pregnancy in#RheumatoidArthritis and next-generation immune monitoring in#Rheumatology research. https://go.nature.com/2tVODSE pic.twitter.com/NIgbCcyDv7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.